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What is already known about this subject
 
• Assessment of endothelial function gives prognostic 
information and allows risk stratification among patients with 
hypertension.
• Existing techniques for determining endothelial function 
involve invasive methods that are not widely applicable 
beyond a research environment.
• A simple non-invasive pulse wave analysis (PWA) method for 
assessing endothelial function has recently been described, 
but its applicability in clinical practice is uncertain.
 
What this study adds
 
• Application of the PWA technique to patients with established 
hypertension is feasible, but endothelial dysfunction was not 
detected.
• Possible discrepancies between different agonists used to 
assess endothelial function might be important and need 
further consideration.
 
Aims
 
Endothelial function is characteristically impaired in patients with hyper tension. Endot-
helial function was assessed in men and women with hyper tension using a recently
described, non-invasive method.
 
Methods
 
Twenty patients and 20 controls received salbutamol 400 
 
µ
 
g and glyceryl trinitrate
(GTN) 500 
 
µ
 
g in a two-way randomized, single-blind study. Effects on augmentation
index (AIx) were assessed using pulse wave analysis (PWA).
 
Results
 
Responses (absolute AIx reduction and 95% confidence interval) to salbutamol were
8.4% (6.2, 10.6) and 8.3% (7.0, 9.6) in patients and controls, respectively, and those
to GTN were 13.6% (10.8, 16.4) and 15.5% (13.0, 17.0), respectively.
 
Conclusions
 
Systemic arterial responses to endothelium-dependent and -independent vasodilators
are preserved in patients with mild, uncomplicated hyper tension, indicating normal
large arterial endothelial function.
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Introduction
 
Impaired endothelial function is an important precursor
to atherosclerosis [1]. Endothelial dysfunction has been
found in animal models of hypertension [2] and in hyper-
tensive patients, in whom forearm blood flow responses
to intrabrachial endothelium-dependent vasodilators are
impaired [3–5]. However, a number of studies have dem-
onstrated no abnormality of endothelial function in
patients with hypertension [6–8]. In one investigation,
endothelium-dependent blood flow responses were found
to show no correlation with blood pressure, whereas
correlations were found for other major cardiovascular
risk factors [9]. It remains controversial whether hyper-
tension alone is sufficient to cause endothelial dysfunc-
tion, or if the association might be explained by
confounding factors. In the setting of raised blood pres-
sure, other risk factors impair endothelial function in an
additive manner [10]. Importantly, endothelial dysfunc-
tion is an independent predictor of cardiovascular events
in patients with hypertension, established peripheral arte-
rial disease and coronary artery disease [11–14]. How-
ever, measurement of endothelial function generally
involves invasive or complex techniques that are not
easily applied beyond specialist research centres [15].
Pulse wave analysis (PWA) has been proposed as a
simple non-invasive means of assessing endothelial func-
tion 
 
in vivo
 
 [16]. Augmentation index (AIx) is a reproduc-
ible measure of large arterial stiffness [17], which is
influenced to some extent by vascular smooth muscle
tone. Salbutamol, a 
 
β
 
2
 
-adrenoceptor agonist, reduces AIx
by stimulating endothelial nitric oxide synthase (NOS)-
dependent vascular relaxation, whereas glyceryl trinitrate
(GTN) relaxes smooth muscle through an endothelium-
independent nitric oxide (NO)-mediated mechanism [18,
19]. PWA allows measurement of AIx responses to
salbutamol and GTN, as endothelium-dependent and
endothelium-independent stimuli, respectively. Where
examined, AIx responses to 
 
β
 
2
 
-adrenoceptor agonists
correspond closely to local blood flow responses to
acetylcholine, a gold standard measure of endothelium-
dependent vasomotion [16, 20]. Furthermore, the PWA
method has identified endothelial dysfunction affecting
conduit arteries in patients with hypercholesterolaemia or
established coronary artery disease [16, 19].
The aim of the present study was to characterize large
arterial endothelial function in patients with hyperten-
sion, using PWA.
 
Methods
 
Study group
 
The protocol was approved by the local research Ethics
Committee and the study was performed in accordance
with the principles outlined in the Declaration of Hels-
inki. Patients were recruited from the Cardiovascular
Risk Clinic of the Lothian University Hospitals NHS
Trust, if seated systolic or diastolic blood pressures were
 
>
 
150 mmHg or 
 
>
 
90 mmHg, respectively, during two
successive readings in clinic, and a diagnosis of hyper-
tension had been established by the attending physician.
These values corresponded to the minimum audit stan-
dards for treated systolic and diastolic pressures at the
time the study was performed. Age- and sex-matched
controls were recruited from a community database of
volunteers held at the Clinical Research Centre of the
University of Edinburgh. All subjects provided written
informed consent. Inclusion criteria were men or women,
aged 30–60 years. Exclusion criteria were a clinical his-
tory of cardiovascular disease, taking any medication except
antihypertensive treatment, regular tobacco use and serum
creatinine 
 
>
 
110 
 
µ
 
mol l
 
−
 
1
 
 or cholesterol 
 
>
 
4.5 mmol l
 
−
 
1
 
.
 
Haemodynamic variables
 
Pulse rate and blood pressure were recorded in the dom-
inant arm using an HEM-705CP device (Omron, Tokyo,
Japan) [21]. The radial artery pressure waveform was
assessed by applanation tonometry (SPC-301 microma-
nometer; Millar Instruments, Houston, TX, USA) and
PWA (SphygmoCor; PWV Medical, Sydney, Australia)
provided a corresponding central pressure waveform,
using a validated transfer function, calibrated using inte-
gral mean arterial pressure [22]. AIx was calculated as
the difference between the second and first central sys-
tolic pressure peaks, expressed as a percentage of central
pulse (systolic 
 
−
 
 diastolic) pressure [23] and the mean
of triplicate recordings was used for data analysis.
 
Study protocol
 
Twenty patients with hypertension and 20 controls were
recruited to a two-way randomized, single-blind study.
Patients were asked to omit their antihypertensive medi-
cations on each study day. All subjects fasted overnight
and studies were performed in the morning, in a quiet
room maintained at 24–26 
 
°
 
C. Subjects rested semisu-
pine for 30 min to establish baseline haemodynamic
conditions and received salbutamol 400 
 
µ
 
g (2 
 
×
 
 200 
 
µ
 
g
Ventolin
 
®
 
; Allen and Hanburys, Uxbridge, UK) inhaled
via a spacer device, or sublingual GTN spray 400 
 
µ
 
g
(Coro-Nitro Pump Spray
 
®
 
; Roche, Welwyn Garden City,
UK). Pulse wave analysis was performed at baseline and
at 5-min intervals up to 20 min after drug administration.
 
Data analysis and statistics
 
The primary outcome variables were maximal AIx
changes after salbutamol or GTN administration, repre-
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senting endothelium-dependent and endothelium-
independent vascular responses, respectively. Subject
numbers were determined to give 
 
>
 
80% power to detect
a 10% difference in the AIx response to salbutamol,
based on previous experience. Responses in patients and
controls were compared using analysis of variance
(
 
ANOVA
 
) and paired Students’ 
 
t
 
-tests, where appropri-
ate. Statistical significance was accepted at the 5% level
in all cases.
 
Results
 
Twenty patients with hypertension (10 men) aged
45 
 
±
 
 5 years (mean 
 
±
 
95% confidence interval) and
20 healthy subjects (10 men) aged 46 
 
±
 
 5 years were
studied. Semisupine systolic blood pressure (SBP) (144
 
vs.
 
 17 mmHg 
 
vs.
 
 115 
 
±
 
 12 mmHg; 
 
P
 
 
 
<
 
 0.005), diastolic
blood pressure (DBP) (90 
 
±
 
 8 mmHg 
 
vs.
 
 64 
 
±
 
 6 mmHg;
 
P
 
 
 
<
 
 0.005), heart rate (70 
 
±
 
 8 min
 
−
 
1
 
 vs.
 
 64 
 
±
 
 5 min
 
−
 
1
 
;
 
P
 
 
 
<
 
 0.01) and body mass index (29.4 
 
±
 
 3.2 kg m
 
−
 
2
 
 vs.
 
27.7 
 
±
 
 2.1 kg m
 
−
 
2
 
; 
 
P
 
 
 
<
 
 0.05) were higher in patients
with hypertension than in controls. Among patients,
55% were receiving no antihypertensive medication,
35% were receiving a thiazide diuretic, 25% were
receiving a 
 
β
 
-blocker, 15% were receiving a calcium
channel antagonist and 5% were receiving an ACE
inhibitor or AT
 
1
 
 receptor antagonist. None was receiving
nitrate therapy.
Baseline AIx was higher in patients than in controls
(27.7 
 
±
 
 2.1% 
 
vs.
 
 20.7 
 
±
 
 2.7%; 
 
P
 
 
 
<
 
 0.05), but AIx re-
sponses to salbutamol and GTN were not significantly
different between groups (Table 1). Salbutamol and
GTN caused no significant effect on heart rate or blood
pressure. The maximal absolute changes in AIx caused
by salbutamol or GTN were similar between patients
and controls (Figure 1). AUC analyses were also per-
formed, which showed AIx responses to salbutamol of
 
Table 1
 
Augmentation index (AIx), heart rate and blood pressure before and after systemic administration of salbutamol or glyceryl trinitrate 
(GTN), as mean 
 
±
 
 95% confidence intervals
 
Healthy control subjects Patients with hypertension
Salbutamol GTN Salbutamol GTN
 
AIx (%)
 
Pre-dose 23.4 
 
± 
 
5.4 20.9 
 
± 
 
4.9 29.2 
 
± 
 
4.3‡ 24.4 
 
± 
 
5.9‡
5 min 21.4 
 
± 
 
5.6 9.6 
 
± 
 
4.4** 27.7 
 
± 
 
4.5 12.1 
 
± 
 
5.5**
10 min 20.3 
 
± 
 
5.6* 9.5 
 
± 
 
5.6** 24.8 
 
± 
 
4.4* 15.3 
 
± 
 
5.1**
15 min 18.6 
 
± 
 
6.1* 10.4 
 
± 
 
5.2** 26.4 
 
± 
 
4.9 20.3 
 
± 
 
3.9*
20 min 20.1 
 
± 
 
6.4 12.9 
 
± 
 
5.5* 26.2 
 
± 
 
5.4 21.7 
 
± 
 
4.6
 
Supine heart rate (min
 
−
 
1
 
)
Pre-dose 63 ± 5 59 ± 3 68 ± 4‡ 66 ± 5‡
5 min 64 ± 4 62 ± 4 69 ± 5 70 ± 5
10 min 63 ± 4 60 ± 3 71 ± 4 69 ± 5
15 min 65 ± 6 60 ± 4 70 ± 5 66 ± 4
20 min 65 ± 5 59 ± 4 70 ± 5 67 ± 5
Supine SBP (mmHg)
Pre-dose 122 ± 7 119 ± 7 142 ± 6‡ 140 ± 6‡
5 min 121 ± 5 118 ± 5 140 ± 6 138 ± 5
10 min 120 ± 6 119 ± 7 141 ± 6 142 ± 6
15 min 121 ± 6 117 ± 6 140 ± 5 138 ± 6
20 min 122 ± 5 118 ± 6 140 ± 6 139 ± 6
Supine DBP (mmHg)
Pre-dose 76 ± 5 75 ± 4 91 ± 4‡ 90 ± 4‡
5 min 76 ± 4 74 ± 5 89 ± 3 88 ± 4
10 min 75 ± 4 75 ± 6 89 ± 3 92 ± 5
15 min 76 ± 5 73 ± 5 90 ± 3 88 ± 4
20 min 75 ± 6 74 ± 6 89 ± 4 90 ± 5
*P < 0.05; **P < 0.01 compared with predose values; ‡P < 0.05 compared with healthy subjects.
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−8.8 ± 43.7 and −21.9 ± 44.4, respectively, in patients
with hypertension and controls (P = 0.39). AUC
responses to glyceryl trinitrate were −208.1 ± 50.6 and
−233 ± 49.7, respectively, in patients with hypertension
and controls (P = 0.73). Linear regression analyses
found no association between AIx and response to salb-
utamol in patients with hypertension (R2 = −0.25, stan-
dard error 8.78) and healthy controls (R2 = −0.25,
standard error 9.69).
Discussion
As expected, patients with hypertension had higher
baseline heart rate, blood pressure and DBP than healthy
controls. Most patients were not receiving antihyperten-
sive therapy because they were recruited after their first
clinic attendance, before treatment had been started.
Higher AIx values in patients with hypertension are
indicative  of  increased  large  arterial  stiffness, as
reported previously [23]. Salbutamol causes
endothelium-dependent NO-mediated vascular relax-
ation, whereas GTN stimulates endothelium-independent
NO-mediated relaxation [19]. The present findings sug-
gest that endothelial function is preserved in patients with
hypertension. This is in contrast to a number of studies
in patients with hypertension that have shown impaired
vasodilator responses using invasive techniques [3–5].
However, a number of earlier studies have found normal
endothelium-dependent vasodilator responses in the
forearm vascular bed of patients with hypertension [6–
9]. Vasoconstrictor responses to L-NMMA, a NOS
antagonist, are preserved in patients with uncomplicated
hypertension, suggesting that constitutive endothelium-
dependent NO bioavailability might indeed be normal
in this patient group [24, 25]. The apparently conflicting
data in patients with hypertension might, at least in
part, be explained by confounding risk factors capable
of impairing endothelial function independently, e.g.
hypercholesterolaemia, diabetes mellitus or the pres-
ence of established atherosclerosis.
A potential limitation of the PWA method is that AIx
is heart rate dependent and this might account for part
of the baseline differences observed between groups
[26]. Nonetheless, the heart rate responses to salbutamol
were similar between patients with hypertension and
controls (3 ± 1 min−1vs. 2 ± 1 min−1) (P = 0.09). A fur-
ther limitation of the technique is that there may be
important differences between the effects of endothe-
lium-dependent agonists. Acetylcholine is the most
widely studied and its responses are linked to both
mechanisms of atherosclerosis and cardiovascular out-
comes. Acetylcholine-mediated vasodilation is only
partly attenuated by pharmacological blockade of NOS
[27] and other mechanisms have been implicated,
including interactions with prostacyclin, endothelin
and endothelium-dependent hyperpolarizing factor. In
hypertension, endothelial dysfunction has previously
been characterized by assessing blood flow responses to
acetylcholine or metacholine, rather than salbutamol.
Agonist-specific defects have been identified in patients
with hypertension [24], and other patient groups, e.g.
vasodilator responses to acetylcholine are impaired but
those to bradykinin preserved in patients with diabetes
mellitus [28], and responses to acetylcholine are
impaired and those to substance P conserved in patients
with chronic heart failure [29]. These suggest that endot-
helial dysfunction might be caused by a specific defect
of muscarinic regulation, which may not alter β2-
receptor-mediated responses.
An important limitation of the present study is that
PWA data were not compared with a gold standard tech-
nique, such as forearm blood flow responses to intrabra-
chial acetylcholine, and additional research is required
to address this point specifically. Additionally, the sub-
ject numbers were comparatively small. Despite this, the
study had >80% power to detect a 10% difference in
AIx responses to salbutamol between patients and con-
trols. A further potential limitation is that only those
with mild hypertension were recruited. Antihypertensive
treatment is capable of influencing endothelial function
independent of effects on blood pressure [30]. Although
antihypertensive therapy was omitted on study days to
minimize this effect, we cannot fully exclude the possi-
bility of drug effects as a confounding factor. Responses
Figure 1
Maximal absolute reduction in augmentation index (AIx) caused by 
salbutamol and glyceryl trinitrate (GTN) administration to patients with 
hypertension () and healthy controls (), shown as mean ± 95% 
confidence intervals
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appeared similar between patients receiving β-blocker
therapy and the general study population, albeit that
subject numbers were small. The study did not have
adequate statistical power to distinguish effects between
treated and untreated patients, but retrospective analysis
did not identify any apparent differences.
In summary, PWA is a novel technique that allows
non-invasive assessment of endothelial function. Using
this method, we found that endothelial function appeared
normal in patients with uncomplicated hypertension.
Therefore, the PWA method may have limited applica-
bility for assessing the effects of various interventions
in this group. The relationships between hypertension
and vascular responses to different endothelium-
dependent vasodilators require further evaluation.
H.M.S. was in receipt of a Wellcome Trust Vacation
Scholarship Grant (VS/FR/2002) and W.S.W. was sup-
ported by a Bristol-Myers Squibb Cardiovascular
Research Fellowship when the research was performed.
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